These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 22640631)

  • 1. mGlu2/3 and mGlu5 receptors: potential targets for novel antidepressants.
    Chaki S; Ago Y; Palucha-Paniewiera A; Matrisciano F; Pilc A
    Neuropharmacology; 2013 Mar; 66():40-52. PubMed ID: 22640631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive impairment in major depression and the mGlu2 receptor as a therapeutic target.
    Goeldner C; Ballard TM; Knoflach F; Wichmann J; Gatti S; Umbricht D
    Neuropharmacology; 2013 Jan; 64():337-46. PubMed ID: 22992331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The potential of group II metabotropic glutamate receptor antagonists as a novel antidepressant].
    Chaki S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Aug; 32(4):219-26. PubMed ID: 23012890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamate-based antidepressants: preclinical psychopharmacology.
    Pilc A; Wierońska JM; Skolnick P
    Biol Psychiatry; 2013 Jun; 73(12):1125-32. PubMed ID: 23453290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mGlu2/3 receptor as a novel target for rapid acting antidepressants.
    Chaki S
    Adv Pharmacol; 2020; 89():289-309. PubMed ID: 32616210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting metabotropic glutamate receptors for the treatment of depression and other stress-related disorders.
    Dogra S; Conn PJ
    Neuropharmacology; 2021 Sep; 196():108687. PubMed ID: 34175327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs.
    Palucha A; Pilc A
    Pharmacol Ther; 2007 Jul; 115(1):116-47. PubMed ID: 17582504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mGlu2/3 Receptor Antagonists as Novel Antidepressants.
    Chaki S
    Trends Pharmacol Sci; 2017 Jun; 38(6):569-580. PubMed ID: 28413097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging treatment mechanisms for depression: focus on glutamate and synaptic plasticity.
    Gerhard DM; Wohleb ES; Duman RS
    Drug Discov Today; 2016 Mar; 21(3):454-64. PubMed ID: 26854424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mGlu receptors as potential targets for novel antidepressants.
    Chaki S; Fukumoto K
    Curr Opin Pharmacol; 2018 Feb; 38():24-30. PubMed ID: 29486373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mGlu2/3 receptor antagonists for depression: overview of underlying mechanisms and clinical development.
    Chaki S; Watanabe M
    Eur Arch Psychiatry Clin Neurosci; 2023 Oct; 273(7):1451-1462. PubMed ID: 36715750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mGlu2/3 receptor antagonists.
    Chaki S
    Adv Pharmacol; 2019; 86():97-120. PubMed ID: 31378257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs.
    Bruno V; Battaglia G; Copani A; D'Onofrio M; Di Iorio P; De Blasi A; Melchiorri D; Flor PJ; Nicoletti F
    J Cereb Blood Flow Metab; 2001 Sep; 21(9):1013-33. PubMed ID: 11524608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabotropic glutamate receptors in the control of mood disorders.
    Witkin JM; Marek GJ; Johnson BG; Schoepp DD
    CNS Neurol Disord Drug Targets; 2007 Apr; 6(2):87-100. PubMed ID: 17430147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Serotonergic System in the Antidepressant Actions of mGlu2/3 Receptor Antagonists: Similarity to Ketamine.
    Chaki S; Fukumoto K
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30871246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Targeting metabotropic glutamate receptors to develop novel antipsychotics].
    Chaki S; Yoshida S; Okuyama S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Nov; 30(5-6):207-13. PubMed ID: 21226317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamate-Based Drug Discovery for Novel Antidepressants.
    Pałucha-Poniewiera A; Pilc A
    Expert Opin Drug Discov; 2016 Sep; 11(9):873-83. PubMed ID: 27409299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of glutamate on the action of antidepressants.
    Hashimoto K
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1558-68. PubMed ID: 20600468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the role of metabotropic glutamate receptors in the mechanisms of action of antidepressants.
    Pałucha A; Pilc A
    Pol J Pharmacol; 2002; 54(6):581-6. PubMed ID: 12866712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Metabotropic glutamate receptors: new molecular targets in the treatment of neurological and psychiatric diseases].
    Luján-Miras R
    Rev Neurol; 2005 Jan 1-15; 40(1):43-53. PubMed ID: 15696426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.